Hecht Beth 4
4 · Xeris Biopharma Holdings, Inc. · Filed Nov 13, 2025
Insider Transaction Report
Form 4
Hecht Beth
See Remarks
Transactions
- Sale
Common Stock
2025-11-11$7.40/sh−16,667$123,296→ 1,336,843 total
Footnotes (2)
- [F1]The transaction was effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person.
- [F2]The price reported in is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.290 to $7.750, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.